A detailed history of Center Book Partners LP transactions in Medtronic PLC stock. As of the latest transaction made, Center Book Partners LP holds 8,767 shares of MDT stock, worth $714,861. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,767
Previous 60,105 85.41%
Holding current value
$714,861
Previous $4.73 Million 83.32%
% of portfolio
0.05%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.84 - $91.03 $3.94 Million - $4.67 Million
-51,338 Reduced 85.41%
8,767 $789,000
Q2 2024

Aug 12, 2024

BUY
$78.71 - $87.02 $2.02 Million - $2.23 Million
25,680 Added 74.6%
60,105 $4.73 Million
Q1 2024

May 10, 2024

BUY
$82.84 - $88.09 $277,431 - $295,013
3,349 Added 10.78%
34,425 $3 Million
Q4 2023

Feb 13, 2024

BUY
$69.43 - $83.43 $895,855 - $1.08 Million
12,903 Added 71.0%
31,076 $2.56 Million
Q3 2023

Nov 13, 2023

BUY
$78.22 - $90.4 $265,869 - $307,269
3,399 Added 23.01%
18,173 $1.42 Million
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $1.93 Million - $2.22 Million
-24,331 Reduced 62.22%
14,774 $1.3 Million
Q1 2023

May 15, 2023

BUY
$76.72 - $87.58 $194,715 - $222,278
2,538 Added 6.94%
39,105 $3.15 Million
Q4 2022

Feb 13, 2023

BUY
$76.18 - $87.74 $533,869 - $614,881
7,008 Added 23.71%
36,567 $2.84 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $29,635 - $34,978
367 Added 1.26%
29,559 $2.39 Million
Q2 2022

Aug 15, 2022

BUY
$87.4 - $113.09 $1.24 Million - $1.61 Million
14,193 Added 94.63%
29,192 $2.62 Million
Q1 2022

May 16, 2022

BUY
$100.58 - $112.38 $620,880 - $693,721
6,173 Added 69.94%
14,999 $1.66 Million
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $878,451 - $1.13 Million
8,826 New
8,826 $913,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.